Caris Life Sciences also found that time-to-next treatment could be a surrogate endpoint for survival.
A genetic testing utilization service launched by Stanford in 2015 helped cut the number of inappropriately ordered tests in half and saved about $250,000 during the first year.
Clinicians in the hospital will use IBM's Watson to identify possible options for diagnosing and treating rare pediatric diseases starting with kidney disease.
Most study participants seem to be increasingly comfortable contributing their genetic results to their electronic medical records as the study progresses.
Use of the blood culture panel in a community hospital setting led to shorter time to targeted treatment for the patient and a shorter stay in the hospital.
The collaboration will explore the clinical utility of Trovagene's platform for detecting and monitoring EGFR mutations in lung cancer patients.
Originally published Oct. 12.
Originally published May 4.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.